ask="N/A"
ask_size="N/A"
average_daily_volume="68712"
bid="1.00"
bid_size="100"
book_value="2.40"
change="-0.05"
change_from_200_day_moving_average="-0.44"
change_from_50_day_moving_average="0.38"
change_from_52_week_high="-4.10"
change_From_52_week_low="1.05"
change_in_percent="-1.08%"
close="4.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.77"
ebitda="-40.42M"
eps_estimate_current_year="-2.01"
eps_estimate_next_quarter="-0.55"
eps_estimate_next_year="-2.13"
ex_dividend_date="N/A"
float_shares="12976000"
high="4.71"
high_52_weeks="8.70"
last_trade_date="3/16/2017"
last_trade_price="4.60"
last_trade_size="1109"
last_trade_time="4:00pm"
low="4.50"
low_52_weeks="3.55"
market_capitalization="107.39M"
moving_average_200_day="5.04"
moving_average_50_day="4.22"
name="ProQR Therapeutics N.V."
notes="N/A"
one_year_target_price="9.50"
open="4.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.81%"
percent_change_from_50_day_moving_average="+8.97%"
percent_change_from_52_week_high="-47.13%"
percent_change_from_52_week_low="+29.47%"
previous_close="4.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.94"
price_per_sales="63.08"
revenue="1.72M"
shares_outstanding="23346000"
short_ratio="3.88"
stock_exchange="NGM"
symbol="PRQR"
volume="35744"
weeks_range_52="3.55 - 8.70"
